BioVidria biovidria.com


Public lists: Pharma Startups (4732)

BioVidria is commercializing high-sensitivity slides for DNA and protein microarrays. The technology utilizes a patented process to provide high surface area and optical transparency. This aims to offer the customer the ability to detect smaller quantities of mRNA, DNA and antigens.

BioVidria is commercializing high-sensitivity slides for DNA and protein microarrays. The technology utilizes a patented process to provide high surface area and optical transparency. This aims to offer the customer the ability to detect smaller quan...Show all

Company (Alive / Active)

Phone: 520-665-1956

Fax:

9040 S. Rita Road
Suite 1100
Tucson, 85747
Arizona, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioVidria $0.7M Jan 2, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioVidria Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Axela Biosensors

Toronto, Ontario, Canada
Alive / ActiveAxela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics. This strategy of offering a common technology platform to both markets aims to provide a opportunity to capitalize on discoveries. The approach has already resulted in applications with the potential to address segments of the large, underserved markets of oncology and cardiology that will be the focus...Show allLogin to see details

CombiMatrix

Mukilteo, Washington, United States
AcquiredCombiMatrix's patented electrochemical manufacturing process utilizes standard semiconductor technology, proprietary software, and chemistry to build arrays of materials -- molecule by molecule.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)